Pheochromocytomas/paragangliomas are characterized by a unique molecular landscape
that allows their assignment to clusters based on underlying genetic alterations. With around …

Pheochromocytoma and paraganglioma (PPGL) require prompt consideration and efficient
diagnosis and treatment to minimize associated morbidity and mortality. Once considered …

Molecular targeted therapy plays an increasingly important role in the treatment of metastatic
pheochromocytomas and paragangliomas (PPGLs), which are rare tumors but remain …

This article aims to review current concepts in diagnosing and managing
pheochromocytoma and paraganglioma (PPGL). Personalized genetic testing is vital, as 40 …

Abstract Context Pheochromocytomas and paragangliomas (PPGLs) with pathogenic
mutations in the succinate dehydrogenase subunit B (SDHB) are associated with a high …

Pheochromocytomas/paragangliomas (PPGL) are rare, metastatic, and potentially fatal
neuroendocrine tumors, often neglected because they present symptoms similar to other …

While the establishment of human phaeochromocytoma and paraganglioma (PPGL) cell
lines has proven to be particularly difficult over several decades of research, there are other …

Aggressive pheochromocytomas and paragangliomas (PPGLs) are difficult to treat, and
molecular targeting is being increasingly considered, but with variable results. This study …

The mammalian adrenal gland is composed of two distinct tissue types in a bidirectional
connection, the catecholamine-producing medulla derived from the neural crest and the …

Objective The effects of sex hormones remain largely unexplored in pheochromocytomas
and paragangliomas (PPGLs) and gastroenteropancreatic neuroendocrine tumors (GEP …